Recombinate (Baxter Healthcare Corporation)
Welcome to the PulseAid listing for the Recombinate drug offered from Baxter Healthcare Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Baxter Healthcare Corporation |
NON-PROPRIETARY NAME: | Antihemophilic Factor Recombinant |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2010-02-08 |
END MARKETING DATE: | 0000-00-00 |
Recombinate HUMAN PRESCRIPTION DRUG Details:
Item Description | Recombinate from Baxter Healthcare Corporation |
LABELER NAME: | Baxter Healthcare Corporation |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2010-02-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0944-2831_6eb61ecd-d264-4163-ba11-26d4816062f3 |
PRODUCT NDC: | 0944-2831 |
APPLICATION NUMBER: | BLA103375 |